Detalles de la búsqueda
1.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355448
2.
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice.
Breast Cancer Res Treat
; 187(2): 455-465, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33646494
3.
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
J Clin Oncol
; 42(13): 1488-1498, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315944
4.
Neoadjuvant systemic treatment in breast cancer surgery: is it always worth it?
Minerva Surg
; 78(5): 510-517, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283507
5.
Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients.
Front Psychol
; 13: 1015573, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36438336
6.
Comparison between male and female breast cancer survival using propensity score matching analysis.
Sci Rep
; 11(1): 11639, 2021 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079019
7.
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine.
Cancers (Basel)
; 12(5)2020 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392708
8.
Results of adjuvant treatment in breast cancer women aged more than 70: Italian cooperative group experience.
Tumori
; 88(1 Suppl 1): S83-5, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11989936
Resultados
1 -
8
de 8
1
Próxima >
>>